COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,725 Articles (22,913 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 480: Articles 4791-4800  | Next

Quantifying the Risk of General Health and Early COVID-19 Spread in Residential Buildings with Deep Learning and Expert-augmented Machine Learning
GUAN, J., LEUNG, E., KWOK, K. O., HUNG, C. T., LEE, A., CHONG, K. C., YAM, C. H. K., CHEUNG, C. K., TIEBEN, H., TSANG, H. W. H., YEOH, E.-k.
10.1101/2023.04.25.23289115 — Posted: 2023-04-28
State and County-Level Factors Associated with the Effectiveness of Stay-At-Home Orders Issued in the United States in Response to COVID-19
Barker, F. D., Mirzadadeh, A., Sekhri Feachem, N.
10.1101/2023.04.27.23289229 — Posted: 2023-04-28
Why are different estimates of the effective reproductive number so different? A case study on COVID-19 in Germany
Brockhaus, E., Wolffram, D., Stadler, T., Osthege, M., Mitra, T., Littek, J. M., Klesen, A. J., Krymova, E., Huisman, J. S., Heyder, S., Helleckes, L. M., an der Heiden, M., Funk, S., Abbott, S., Bracher, J.
10.1101/2023.04.27.23289109 — Posted: 2023-04-28
Demographic Influence on the Effectiveness of England's SARS-CoV-2 Policies
Dhada, M., Labra Montes, J.
10.1101/2023.04.25.23288871 — Posted: 2023-04-28
Spatial clusters and social inequities in Covid-19 vaccine coverage among children in Brazil
BOING, A. C. S., BOING, A. F., Borges, M. E., Rodrigues, D. d. O., Barberia, L., Subramanian, S.
10.1101/2023.04.25.23289089 — Posted: 2023-04-28
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 that Exhibits Antiviral Efficacy in SARS-CoV-2 Infected African Green Monkeys
Mackman, R. L., Kalla, R., Babusis, D., Pitts, J., Barrett, K. T., Chun, K., Du Pont, V., Rodriguez, L., Moshiri, J., Xu, Y., Lee, M., Lee, G., Bleier, B., Nguyen, A.-Q., O'Keefe, B. M., Ambrosi, A., Cook, M., Yu, J., Dempah, K. E., Bunyan, E., Riola, N. C., Lu, X., Liu, R., Davie, A., Hsiang, T.-Y., Gale, M., Niedziela-Majka, A., Feng, J. Y., Hedskog, C., Bilello, J. P., Subramanian, R., Cihlar, T.
10.1101/2023.04.28.538473 — Posted: 2023-04-28
Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbidities
Madera-Sandoval, R. L., Cerbulo-Vazquez, A., Arriaga-Pizano, L. A., Cabrera-Rivera, G. L., Basilio-Galveza, E., Miranda-Cruz, P. E., Garcia de la Rosa, M. T., Prieto-Chavez, J. L., Rivero-Arredondo, S. V., Cruz-Cruz, A., Rodriguez-Hernandez, D., Salazar-Rios, M. E., Salazar-Rios, E., Serrano-Molina, E. D., De Lira-Barraza, R. C., Villanueva-Compean, A. H., Esquivel-Pineda, A., Ramirez-Montes de Oca, R., Unzueta-Marta, O., Flores-Padilla, G., Anda-Garay, J. C., Sanchez-Hurtado, L. A., Calleja-Alarcon, S., Romero-Gutierrez, L., Torres-Rosas, R., Bonifaz, L. C., Pelayo, R., Marquez-Marquez, E., L
10.1101/2023.04.25.23288937 — Posted: 2023-04-27
The impact of long-term conditions and comorbidity patterns on COVID-19 infection and hospitalisation: a cohort study
Huang, Y.-T., Steptoe, A., Patel, R., Fuller-Thomson, E., Cadar, D.
10.1101/2023.04.25.23289035 — Posted: 2023-04-27
Stent For Life Initiative in Portugal: progress through years and Covid-19 Impact
Pereira, E., Cale, R., Pereira, A. M., Pereira, H., Martins, L. D.
10.1101/2023.04.25.23288494 — Posted: 2023-04-27
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
Song, G., Yuan, M., Liu, H., Capozzola, T., Lin, R. N., Torres, J. L., He, W.-t., Musharrafieh, R., Dueker, K., Zhou, P., Callaghan, S., Mishra, N., Yong, P., Anzanello, F., Avillion, G., Vo, A. L., Li, X., Makhdoomi, M., Feng, Z., Zhu, X., Peng, L., Nemazee, D., Safonova, Y., Briney, B., Ward, A. B., Burton, D. R., Wilson, I. A., Andrabi, R.
10.1101/2023.04.26.538488 — Posted: 2023-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).